Fiona M Ross

Fiona M Ross

UNVERIFIED PROFILE

Are you Fiona M Ross?   Register this Author

Register author
Fiona M Ross

Fiona M Ross

Publications by authors named "Fiona M Ross"

Are you Fiona M Ross?   Register this Author

57Publications

833Reads

-Profile Views

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2019 01 10;10(1):213. Epub 2019 Jan 10.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-08107-8
Publisher Site
http://dx.doi.org/10.1038/s41467-018-08107-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328616PMC
January 2019

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2018 09 13;9(1):3707. Epub 2018 Sep 13.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-04989-w
Publisher Site
http://dx.doi.org/10.1038/s41467-018-04989-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137048PMC
September 2018

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.

Genes Chromosomes Cancer 2015 Feb 7;54(2):91-8. Epub 2014 Oct 7.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Service des maladies du Sang, Hopital Huriez, Centre Hospitalier Regional Universitaire de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310140PMC
February 2015

Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment.

Clin Cancer Res 2013 Nov 30;19(21):6030-8. Epub 2013 Aug 30.

Authors' Affiliations: Institute of Cancer Research, Royal Marsden Hospital, London; Clinical Trials Research Unit, University of Leeds; St James's University Hospital, Leeds; University of Birmingham, Birmingham; Wessex Regional Genetics Laboratory, University of Southampton, Salisbury; and University of Newcastle, Newcastle-upon-Tyne, United Kingdom.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2013/08/
Web Search
http://clincancerres.aacrjournals.org/content/19/21/6030.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-3211DOI Listing
November 2013

Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma.

Leuk Lymphoma 2013 Sep 23;54(9):1975-81. Epub 2013 Jan 23.

Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.760736DOI Listing
September 2013

Identification of a novel t(7;14) translocation in multiple myeloma resulting in overexpression of EGFR.

Genes Chromosomes Cancer 2013 Sep 13;52(9):817-22. Epub 2013 Jun 13.

Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22077DOI Listing
September 2013

Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.

Br J Haematol 2013 Apr 29;161(2):291-4. Epub 2013 Jan 29.

Division of Molecular Pathology, Haemato-Oncology Research Unit, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12218DOI Listing
April 2013

Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.

Blood 2013 Apr 22;121(17):3413-9. Epub 2013 Feb 22.

Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-12-47
Publisher Site
http://dx.doi.org/10.1182/blood-2012-12-471888DOI Listing
April 2013

Informal stroke caregivers' self-appraised problem-solving abilities as a predictor of well-being and perceived social support.

J Clin Nurs 2012 Jan 24;21(1-2):232-42. Epub 2011 Jun 24.

The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2702.2011.03742.xDOI Listing
January 2012

A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment.

Clin Cancer Res 2011 Oct 19;17(19):6347-55. Epub 2011 Aug 19.

Section of Haemato-Oncology Research Unit, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-0994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866998PMC
October 2011

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.

Haematologica 2009 Dec;94(12):1708-13

Leukaemia Research Fund UK Myeloma Forum Cytogenetics Group, Human Genetics Division, University of Southampton, Wessex Regional Genetics Laboratory, Salisbury District Hospital, Wilts, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.011064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791926PMC
December 2009

Frequent upregulation of MYC in plasma cell leukemia.

Genes Chromosomes Cancer 2009 Jul;48(7):624-36

Leukaemia Research Fund UK Myeloma Forum Cytogenetics Group, Human Genetics Division, University of Southampton, Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, Wilts, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20670DOI Listing
July 2009

Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case.

Haematologica 2009 Jul 19;94(7):1024-8. Epub 2009 May 19.

Leukaemia Research Fund UK Myeloma Forum Cytogenetics Group, Human Genetics Division, University of Southampton, Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, Wilts, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2008.004440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704316PMC
July 2009

Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.

Proc Natl Acad Sci U S A 2008 Nov 28;105(44):17050-4. Epub 2008 Oct 28.

Cancer Genomics and Leukaemia Research Cytogenetics Groups, Cancer Sciences Division, University of Southampton, Southampton, SO16 6YD, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0803494105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579376PMC
November 2008

Service user involvement and integrated care pathways.

Int J Health Care Qual Assur 2007 ;20(2-3):195-214

Nursing Research Unit, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1108/09526860710743345DOI Listing
January 2008

Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma.

Blood 2006 Sep 16;108(5):1733-43. Epub 2006 May 16.

Section of Haemato-Oncology, Institute for Cancer Research, 15 Cotswold Rd, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-02-005496DOI Listing
September 2006

Supporting family caregivers in stroke care: a review of the evidence for problem solving.

Stroke 2005 Nov 6;36(11):2514-22. Epub 2005 Oct 6.

The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.STR.0000185743.41231.85DOI Listing
November 2005

Karyotyping lymph node biopsies in non-Hodgkin's lymphoma.

Methods Mol Med 2005 ;115:93-107

Wessex Regional Genetics Laboratory, Salisbury District Hospital, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-936-2:093DOI Listing
August 2005

Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.

Genes Chromosomes Cancer 2004 May;40(1):78-83

Wessex Regional Genetics Laboratory, Salisbury, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20023DOI Listing
May 2004

The context, measures and outcomes of psychosocial care interventions in long-term health care for older people.

Int J Nurs Pract 2004 Feb;10(1):39-44

St George's Hospital Medical School, London, United Kingdom.

View Article

Download full-text PDF

Source
February 2004

A dual role for interleukin-1 in LTP in mouse hippocampal slices.

J Neuroimmunol 2003 Nov;144(1-2):61-7

School of Biological Sciences, University of Manchester, 1.124 Stopford Building, Oxford Road, Manchester, M13 9PT, UK.

View Article

Download full-text PDF

Source
November 2003

Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.

Br J Haematol 2002 May;117(2):427-35

Department of Haematology, Royal Free and University College Medical School, London, UK.

View Article

Download full-text PDF

Source
May 2002